Colgate-Palmolive(US:CL) ZACKSยท2024-07-26 14:36Core Insights - Colgate-Palmolive reported revenue of $5.06 billion for the quarter ended June 2024, reflecting a year-over-year increase of 4.9% and surpassing the Zacks Consensus Estimate of $5.01 billion by 0.93% [1] - The company's EPS for the quarter was $0.91, up from $0.77 in the same quarter last year, exceeding the consensus EPS estimate of $0.87 by 4.60% [1] Revenue Performance by Region - North America: Net sales of $1 billion, a 2.5% increase year-over-year, below the average estimate of $1.01 billion [2] - Latin America: Net sales of $1.27 billion, a 7.6% increase year-over-year, slightly below the average estimate of $1.30 billion [2] - Africa/Eurasia: Net sales of $273 million, a 1.9% increase year-over-year, exceeding the average estimate of $247.25 million [2] - Europe: Net sales of $720 million, a 6.2% increase year-over-year, above the average estimate of $709.41 million [2] - Asia Pacific: Net sales of $682 million, a 2.7% increase year-over-year, surpassing the average estimate of $649.87 million [2] - Pet Nutrition: Net sales of $1.11 billion, a 5.5% increase year-over-year, slightly above the average estimate of $1.10 billion [2] - Total Oral, Personal and Home Care: Net sales of $3.94 billion, a 4.7% increase year-over-year, exceeding the average estimate of $3.92 billion [2] Operating Profit - Total Oral, Personal and Home Care: Operating profit of $1.06 billion, above the average estimate of $1.04 billion [2] - Corporate: Operating profit of -$201 million, worse than the average estimate of -$168.56 million [2] - Pet Nutrition: Operating profit of $235 million, exceeding the average estimate of $211.17 million [2] Stock Performance - Colgate-Palmolive shares have returned -1.7% over the past month, compared to the Zacks S&P 500 composite's -1.2% change, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]